Company profilePharmaceutical#171 of 1,318 in Pakistan1 DRAP alert

EPOCH PHARMACEUTICAL

Pharmaceutical company · 104 brands · 101 molecules

Ranked #6 of 50 companies in Anti-Infective, Ophthalmologicals

104 registered products 38 pharmaceutical brands 101 distinct molecules 1 DRAP alert

Company overview

104

registered products

pharmaceutical brands

101

distinct molecules

therapeutic classes

DRAP alerts

EPOCH PHARMACEUTICAL is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 104 product registrations across 101 distinct molecules. It is the 171st largest registrant in Pakistan by product count, and ranks 6th of 50 in Anti-Infective, Ophthalmologicals. Its portfolio is concentrated in Anti-Infective, Ophthalmologicals and Antithrombotic Agents. DRAP has issued 1 alert involving its products.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Top molecules by brand count

Eye8 brands

Gentamicin6 brands

Pyridoxine4 brands

Cyanocobalamin4 brands

Dexamethasone3 brands

Ear3 brands

Thiamine3 brands

Famotidine3 brands

Fusidic Acid3 brands

Metronidazole3 brands

Therapeutic classes

Regulatory record

1 alert in the DRAP feed we track.

Recall Alert; Drug Product: Phenerzine Elixir (Batch # 037) by M/s Epoch Pharmaceuticals (

2022-08-02

Competitive set

Companies whose registered portfolio overlaps most with this one.

Wilshire Laboratories (Private) Limited41 shared molecules

ZAFA PHARMACEUTICAL LABORATORIES (PVT) LTD.39 shared molecules

EFROZE CHEMICAL INDUSTRIES (PVT) LTD.35 shared molecules

KRKA-PAK PHARMACEUTICAL & CHEMICAL WORKS34 shared molecules

IRZA PHARMA (PVT) LTD.34 shared molecules

NEUTRO PHARMA (PVT) LTD.34 shared molecules

Atco Pharma International (Pvt) Ltd33 shared molecules

POLYFINE CHEMPHARMA (PVT) LTD.33 shared molecules

Albro Pharmaceuticals33 shared molecules

SEMOS PHARMACEUTICALS (PVT) LTD.32 shared molecules

Get the full profile for EPOCH

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included